MASSIMO BROGGINI

Laboratory Head

Istituto di Ricerche Farmacologiche Mario Negri

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Massimo Broggini is the Laboratory Head at Istituto di Ricerche Farmacologiche Mario Negri in Italy. His research areas focus on cancer biology, specifically in non-small cell lung cancer (NSCLC) and its metabolic pathways, as evidenced by his recent publications. His work includes investigating molecular changes associated with cancer cachexia, resistance mechanisms to PI3K/mTOR inhibitors, and novel therapeutic options for NSCLC. He is also engaged in studying host-pathogen interactions, particularly concerning copper metabolism and influenza infection.

Articles (10)

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Angela Rizzo

University of Milan

ITALY

View details

Mirko Marabese

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Luc Furic

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

MASSIMO BROGGINI

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Early molecular changes predict cancer cachexia in LKB1‐deleted mouse models of NSCLC

The Landscape of PARP Inhibitors in Solid Cancers

NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2)

The Crossroads between Host Copper Metabolism and Influenza Infection

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation

Predicting the Role of DNA Polymerase β Alone or with <i>KRAS</i> Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients

Anti-Influenza Effect of Nanosilver in a Mouse Model

It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?

Collaborators (3)

Angela Rizzo

Mirko Marabese

Luc Furic

Make your next move.